Treatment of Intertrigo Complicated by Group A Beta-Hemolytic Streptococcal Skin Infection

When intertrigo is complicated by a group A beta-hemolytic streptococcal skin infection, managing the bacterial component becomes central to treatment — standard skin-fold measures alone are insufficient.

Clinical scenario: Intertrigo with group A beta-hemolytic streptococcal skin infection — a bacterial complication requiring targeted antimicrobial therapy alongside local skin-fold management.

Treatment approach

The approach involves a combination of topical antimicrobial therapy and oral antibiotic therapy, together with a low-potency topical steroid — the specific agents, regimen options, and selection criteria are detailed in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

The optimal treatment for patients with intertrigo and group A beta-hemolytic streptococcal infections includes single or multiple regimens of topical therapies (e.g., mupirocin [Bactroban], erythromycin); oral antibiotics (e.g., penicillin, first-generation cephalosporins); and low-potency topical steroids (e.g., hydrocortisone 1% cream).

View source ↗